文献速递冠心病血脂与心血管预防

冠状动脉血运重建术后卒中发生率:外科手术与经皮冠状动脉介入治疗的比较

Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

该研究汇总了11项随机临床试验的个体患者数据,比较冠状动脉旁路移植术(CABG)与经皮冠状动脉介入治疗(PCI)后的卒中发生率及卒中对长期死亡率的影响。共纳入11,518例患者,随访3.8±1.4年,结果显示PCI组5年卒中率显著低于CABG组(2.6% vs 3.2%),差异主要由术后30天内卒中风险降低驱动,而31天至5年期间两组卒中风险相似。CABG后卒中风险增高仅限于多支病变合并糖尿病患者。术后30天内发生卒中的患者5年死亡率显著升高。

要点

  • PCI组5年卒中率显著低于CABG组(2.6% vs 3.2%,HR 0.77,95%CI 0.61-0.97,p=0.027)。
  • 30天卒中率PCI组为0.4%,CABG组为1.1%(HR 0.33,95%CI 0.20-0.53,p<0.001)。
  • 术后30天内发生卒中者5年死亡率显著高于无卒中者(PCI 45.7% vs 11.1%;CABG 41.5% vs 8.9%)。

核心结论

  • PCI术后5年卒中率显著低于CABG,主要归因于术后30天内卒中风险降低,而31天至5年期间两组风险相似。
  • CABG相比PCI的卒中风险增高仅限于多支病变合并糖尿病患者。
  • 术后30天内发生卒中的患者5年死亡率显著升高。

研究设计与样本

  • 研究为11项比较CABG与PCI(使用支架)的随机临床试验的个体患者数据协作汇总分析。
  • 共纳入11,518例患者,随机分配至PCI(n=5,753)或CABG(n=5,765),平均随访3.8±1.4年。
  • 采用随机效应Cox比例风险模型,按试验分层,比较30天和5年卒中率,并探索卒中对5年死亡率的影响。

主要发现

  • 随访期间共发生293例卒中。
  • 30天卒中率:PCI组0.4%,CABG组1.1%(HR 0.33;95%CI 0.20-0.53;p<0.001)。
  • 5年卒中率:PCI组2.6%,CABG组3.2%(HR 0.77;95%CI 0.61-0.97;p=0.027)。
  • 31天至5年卒中率:PCI组2.2%,CABG组2.1%(HR 1.05;95%CI 0.80-1.38;p=0.72)。
  • 糖尿病交互作用:糖尿病患者PCI 2.6% vs CABG 4.9%,非糖尿病患者PCI 2.6% vs CABG 2.4%(交互作用p=0.004)。

临床怎么用

  • 对于多支病变合并糖尿病患者,选择血运重建方式时应权衡CABG带来的卒中风险增加。
  • 术后30天内发生卒中的患者长期死亡风险显著升高,需加强围术期卒中预防和监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are used for coronary revascularization in patients with multivessel and left main coronary artery disease. Stroke is among the most feared complications of revascularization. Due to its infrequency, studies with large numbers of patients are required to detect differences in stroke rates between CABG and PCI. OBJECTIVES: This study sought to compare rates of stroke after CABG and PCI and the impact of procedural stroke on long-term mortality. METHODS: We performed a collaborative individual patient-data pooled analysis of 11 randomized clinical trials comparing CABG with PCI using stents; ERACI II (Argentine Randomized Study: Coronary Angioplasty With Stenting Versus Coronary Bypass Surgery in Patients With Multiple Vessel Disease) (n = 450), ARTS (Arterial Revascularization Therapy Study) (n = 1,205), MASS II (Medicine, Angioplasty, or Surgery Study) (n = 408), SoS (Stent or Surgery) trial (n = 988), SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) trial (n = 1,800), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) trial (n = 600), FREEDOM (Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes) trial (n = 1,900), VA CARDS (Coronary Artery Revascularization in Diabetes) (n = 198), BEST (Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease) (n = 880), NOBLE (Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in Treatment of Unprotected Left Main Stenosis) trial (n = 1,184), and EXCEL (Evaluation of Xience Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial (n = 1,905). The 30-day and 5-year stroke rates were compared between CABG and PCI using a random effects Cox proportional hazards model, stratified by trial. The impact of stroke on 5-year mortality was explored. RESULTS: The analysis included 11,518 patients randomly assigned to PCI (n = 5,753) or CABG (n = 5,765) with a mean follow-up of 3.8 ± 1.4 years during which a total of 293 strokes occurred. At 30 days, the rate of stroke was 0.4% after PCI and 1.1% after CABG (hazard ratio [HR]: 0.33; 95% confidence interval [CI]: 0.20 to 0.53; p < 0.001). At 5-year follow-up, stroke remained significantly lower after PCI than after CABG (2.6% vs. 3.2%; HR: 0.77; 95% CI: 0.61 to 0.97; p = 0.027). Rates of stroke between 31 days and 5 years were comparable: 2.2% after PCI versus 2.1% after CABG (HR: 1.05; 95% CI: 0.80 to 1.38; p = 0.72). No significant interactions between treatment and baseline clinical or angiographic variables for the 5-year rate of stroke were present, except for diabetic patients (PCI: 2.6% vs. CABG: 4.9%) and nondiabetic patients (PCI: 2.6% vs. CABG: 2.4%) (p for interaction = 0.004). Patients who experienced a stroke within 30 days of the procedure had significantly higher 5-year mortality versus those without a stroke, both after PCI (45.7% vs. 11.1%, p < 0.001) and CABG (41.5% vs. 8.9%, p < 0.001). CONCLUSIONS: This individual patient-data pooled analysis demonstrates that 5-year stroke rates are significantly lower after PCI compared with CABG, driven by a reduced risk of stroke in the 30-day post-procedural period but a similar risk of stroke between 31 days and 5 years. The greater risk of stroke after CABG compared with PCI was confined to patients with multivessel disease and diabetes. Five-year mortality was markedly higher for patients experiencing a stroke within 30 days after revascularization.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Head SJ, Milojevic M, Daemen J, et al. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization. J Am Coll Cardiol. 2018. PMID: 30025574. doi:10.1016/j.jacc.2018.04.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。